Deep Dive – Patients and Partnerships

Patient centricity is continually evolving

The world is slowly, gradually, hopefully emerging from the shadow of COVID-19 and as it does so there is, as Alnylam’s Kasha Witkos notes in this issue, a unique opportunity to re-discover what matters most to patients.

“Patient centricity is continually evolving and as an industry, we must evolve with it if we are to leave a legacy where we can say we made the biggest difference we possibly could,” she explains.

Patient access also features prominently in this issue of the magazine, with Astellas Pharma Europe vice president of global pricing Mig Sleeper explaining why it’s time to rethink how value is defined.